Appreciate the link to the article!
The trial is definitely optimistic news for those of us that have a high probability of re occurrence for T1G3 and/or CIS BC. Hopefully, the trials make their way through the various milestones, and the treatment becomes available sooner than later. Just a curious thought...if the treatment works well, will it become the gold standard and replace BCG as a 1st line option??? I guess time will tell.
Regards,
Gordo